ALR - Alere Inc.

NYSE - NYSE Delayed Price. Currency in USD
50.99
-50.99 (-100.00%)
Stock chart is not supported by your current browser
Previous Close50.99
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Moody's12 days ago

    Alere Inc. -- Moody's to withdraw Alere's ratings following debt redemption

    Rating Action: Moody's to withdraw Alere's ratings following debt redemption. Global Credit Research- 05 Oct 2017. New York, October 05, 2017-- Moody's Investors Service will withdraw Alere Inc.' s ratings ...

  • Abbott to Gain from Alere's Takeover Due for Oct 3 Closure
    Zacks15 days ago

    Abbott to Gain from Alere's Takeover Due for Oct 3 Closure

    Alere's acquisition would help Abbott (ABT) explore new channels and geographies, including forays into fast growing outlets like doctors' offices, clinics, pharmacies and at-home testing.

  • Market Realist15 days ago

    Abbott-Alere Deal Wins Conditional US Antitrust Approval

    The Federal Trade Commission recently announced the US antitrust approval for Abbott Laboratories' (ABT) acquisition of Alere (ALR).

  • See what the IHS Markit Score report has to say about Alere Inc.
    Markit15 days ago

    See what the IHS Markit Score report has to say about Alere Inc.

    Short interest is low for ALR with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding ALR are favorable, with net inflows of $2.40 billion.

  • GuruFocus.com18 days ago

    Alere Reaches Settlement With SEC

    The company will pay $13 million

  • Abbott Labs' Torturous Deal Saga Isn't Over Yet
    Bloomberg18 days ago

    Abbott Labs' Torturous Deal Saga Isn't Over Yet

    The takeover is set to close next week, but the medical-device maker still has to prove it was all worth it.

  • The Wall Street Journal19 days ago

    [$$] Alere Settles With SEC Over Accounting-Fraud Allegations

    Alere Inc. has agreed to pay $13 million to settle allegations from the Securities and Exchange Commission that its foreign subsidiaries committed accounting fraud and used third parties to make improper ...

  • TheStreet.com19 days ago

    FTC Approves Abbott's Acquisition of Alere, Stock Jumps

    Abbott was able to reach a deal to buy Alere in April for around $5.3 billion, below its initial $5.8 billion offer.

  • Abbott wins U.S. antitrust approval to buy Alere with conditions
    Reuters19 days ago

    Abbott wins U.S. antitrust approval to buy Alere with conditions

    Abbott Laboratories has won U.S. antitrust approval to buy Alere Inc on condition that it sell two point-of-care medical testing businesses, the Federal Trade Commission said on Thursday. Alere's shares were up 3.5 percent at $50.61 in mid-afternoon trading on Thursday while Abbott was up 3 percent at $53.72. Abbott first offered to buy Alere in February 2016, but the deal ran into trouble because of issues related to the diagnostic maker's accounting and sales practices.

  • Reuters19 days ago

    Alere to pay more than $13 million to resolve U.S. SEC probe

    Alere Inc has agreed to pay more than $13 million to resolve charges the diagnostic testing firm committed accounting fraud and made improper payments to foreign officials, the U.S. Securities and Exchange Commission said on Thursday. The settlement with Alere resolved an investigation that began in 2015 before Abbott Laboratories agreed to buy the Waltham, Massachusetts-based company in a $5.3 billion deal expected to close later this year.

  • Alere, Inc. – Value Analysis (NYSE:ALR) : September 21, 2017
    Capital Cube27 days ago

    Alere, Inc. – Value Analysis (NYSE:ALR) : September 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Alere, Inc. a score of 6. Our analysis is based on comparing Alere, Inc. with the following peers – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A, Abbott Laboratories, Chembio Diagnostics, Inc., Danaher Corporation, Procter & Gamble Company, Hill-Rom Holdings, Inc., OraSure Technologies, Inc., Meridian Bioscience, Inc. and ... Read more (Read more...)

  • Here's Why Quidel Corporation Stock Is Popping Today
    Motley Fool28 days ago

    Here's Why Quidel Corporation Stock Is Popping Today

    Investors appear pleased with a recent revision to a deal with another point-of-care diagnostic developer.

  • Alere, Inc. breached its 50 day moving average in a Bullish Manner : ALR-US : September 19, 2017
    Capital Cube28 days ago

    Alere, Inc. breached its 50 day moving average in a Bullish Manner : ALR-US : September 19, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alere, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Alere Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Alere Inc.

    Short interest is low for ALR with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold ALR had net inflows of $945 million over the last one-month.

  • Alere, Inc. breached its 50 day moving average in a Bearish Manner : ALR-US : September 8, 2017
    Capital Cubelast month

    Alere, Inc. breached its 50 day moving average in a Bearish Manner : ALR-US : September 8, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alere, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Alere Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about Alere Inc.

    Short interest is low for ALR with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on August 7. The net inflows of $369 million over the last one-month into ETFs that hold ALR are among the lowest of the last year and appear to be slowing.

  • See what the IHS Markit Score report has to say about Alere Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Alere Inc.

    Short interest is low for ALR with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on August 7. ETFs that hold ALR had net inflows of $828 million over the last one-month.

  • New Strong Sell Stocks for August 28th
    Zacks2 months ago

    New Strong Sell Stocks for August 28th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Capital Cube2 months ago

    ETFs with exposure to Alere, Inc. : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alere, Inc. Here are 5 ETFs with the largest exposure to ALR-US. Comparing the performance and risk of Alere, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Alere, Inc. :ALR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cube2 months ago

    Alere, Inc. :ALR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Alere, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Alere, Inc. – Quidel Corporation, Bio-Rad Laboratories, Inc. Class A, Abbott Laboratories, Chembio Diagnostics, Inc., Danaher Corporation, Procter & Gamble Company, Hill-Rom Holdings, Inc., OraSure Technologies, Inc., Meridian Bioscience, ... Read more (Read more...)

  • See what the IHS Markit Score report has to say about Alere Inc.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Alere Inc.

    Short interest is low for ALR with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on August 7. ETFs that hold ALR had net inflows of $1.19 billion over the last one-month.

  • Alere, Inc. breached its 50 day moving average in a Bearish Manner : ALR-US : August 4, 2017
    Capital Cube2 months ago

    Alere, Inc. breached its 50 day moving average in a Bearish Manner : ALR-US : August 4, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alere, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Market Realist3 months ago

    What Were Abbott’s Key Growth Drivers for 2Q17?

    Abbott completed the acquisition of St. Jude Medical in January 2017. It contributed significantly to its 2Q17 sales.